215 related articles for article (PubMed ID: 34787092)
1. Irritable Bowel Syndrome on Inflammatory Bowel Disease in Deep Remission: No Relation with Remission Deepening and Inflammation.
Sezgin O; Boztepe B; Üçbilek E; Altintas E; Celikcan HD
Turk J Gastroenterol; 2021 Oct; 32(10):870-878. PubMed ID: 34787092
[TBL] [Abstract][Full Text] [Related]
2. Presence of Irritable Bowel Syndrome Symptoms in Quiescent Inflammatory Bowel Disease Is Associated with High Rate of Anxiety and Depression.
Perera LP; Radigan M; Guilday C; Banerjee I; Eastwood D; Babygirija R; Massey BT
Dig Dis Sci; 2019 Jul; 64(7):1923-1928. PubMed ID: 30725303
[TBL] [Abstract][Full Text] [Related]
3. The prevalence of irritable bowel syndrome-type symptoms in inflammatory bowel disease patients in remission.
Hoekman DR; Zeevenhooven J; D'Haens GR; Benninga MA
Eur J Gastroenterol Hepatol; 2017 Sep; 29(9):1086-1090. PubMed ID: 28639969
[TBL] [Abstract][Full Text] [Related]
4. Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease.
D'Haens G; Ferrante M; Vermeire S; Baert F; Noman M; Moortgat L; Geens P; Iwens D; Aerden I; Van Assche G; Van Olmen G; Rutgeerts P
Inflamm Bowel Dis; 2012 Dec; 18(12):2218-24. PubMed ID: 22344983
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of noninvasive evaluations in monitoring inflammatory bowel disease activity: A prospective study in China.
Chen JM; Liu T; Gao S; Tong XD; Deng FH; Nie B
World J Gastroenterol; 2017 Dec; 23(46):8235-8247. PubMed ID: 29290660
[TBL] [Abstract][Full Text] [Related]
6. The prevalence of irritable bowel syndrome-type symptoms in paediatric inflammatory bowel disease, and the relationship with biochemical markers of disease activity.
Diederen K; Hoekman DR; Hummel TZ; de Meij TG; Koot BG; Tabbers MM; Vlieger AM; Kindermann A; Benninga MA
Aliment Pharmacol Ther; 2016 Jul; 44(2):181-8. PubMed ID: 27110920
[TBL] [Abstract][Full Text] [Related]
7. Irritable Bowel Syndrome-Like Symptoms in Ulcerative Colitis Patients in Clinical Remission: Association with Residual Colonic Inflammation.
Ishihara S; Kawashima K; Fukuba N; Tada Y; Kotani S; Mishima Y; Oshima N; Kinoshita Y
Digestion; 2019; 99(1):46-51. PubMed ID: 30554229
[TBL] [Abstract][Full Text] [Related]
8. Patients with longstanding ulcerative colitis in remission do not have more irritable bowel syndrome-like symptoms than controls.
Lundgren D; Rutegård J; Eklöf V; Palmqvist R; Karling P
BMC Gastroenterol; 2016 Nov; 16(1):139. PubMed ID: 27881072
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of irritable bowel syndrome-like symptoms in ulcerative colitis patients with clinical and endoscopic evidence of remission: prospective multicenter study.
Fukuba N; Ishihara S; Tada Y; Oshima N; Moriyama I; Yuki T; Kawashima K; Kushiyama Y; Fujishiro H; Kinoshita Y
Scand J Gastroenterol; 2014 Jun; 49(6):674-80. PubMed ID: 24646420
[TBL] [Abstract][Full Text] [Related]
10. Characterization of IBS-like symptoms in patients with ulcerative colitis in clinical remission.
Jonefjäll B; Strid H; Ohman L; Svedlund J; Bergstedt A; Simren M
Neurogastroenterol Motil; 2013 Sep; 25(9):756-e578. PubMed ID: 23731196
[TBL] [Abstract][Full Text] [Related]
11. Faecal calprotectin as a novel biomarker for differentiating between inflammatory bowel disease and irritable bowel syndrome.
Chang MH; Chou JW; Chen SM; Tsai MC; Sun YS; Lin CC; Lin CP
Mol Med Rep; 2014 Jul; 10(1):522-6. PubMed ID: 24788223
[TBL] [Abstract][Full Text] [Related]
12. Comparative characteristics of fatigue in irritable bowel syndrome and inflammatory bowel disease: A systematic review and meta-analysis.
Kim YJ; Lee SG; Lee JS; Choi YJ; Son CG
J Psychosom Res; 2024 Feb; 177():111589. PubMed ID: 38199049
[TBL] [Abstract][Full Text] [Related]
13. Role of Calprotectin, IL-6, and CRP in Distinguishing Between Inflammatory Bowel Disease and Diarrhea Predominant Irritable Bowel Syndrome.
Huong BT; Hien NM; Dung NT; Quang DM; Vinh NT; Tu TT; Chi TK; Phuong LB; Nhan NT
Med Arch; 2024; 78(2):105-111. PubMed ID: 38566874
[TBL] [Abstract][Full Text] [Related]
14. Irritable Bowel-like Symptoms in Ulcerative Colitis are as Common in Patients in Deep Remission as in Inflammation: Results From a Population-based Study [the IBSEN Study].
Henriksen M; Høivik ML; Jelsness-Jørgensen LP; Moum B;
J Crohns Colitis; 2018 Mar; 12(4):389-393. PubMed ID: 29186372
[TBL] [Abstract][Full Text] [Related]
15. Low Fecal Calprotectin Correlates with Histological Remission and Mucosal Healing in Ulcerative Colitis and Colonic Crohn's Disease.
Zittan E; Kelly OB; Kirsch R; Milgrom R; Burns J; Nguyen GC; Croitoru K; Van Assche G; Silverberg MS; Steinhart AH
Inflamm Bowel Dis; 2016 Mar; 22(3):623-30. PubMed ID: 26829408
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of irritable bowel syndrome-type symptoms in patients with inflammatory bowel disease in remission: a systematic review and meta-analysis.
Fairbrass KM; Costantino SJ; Gracie DJ; Ford AC
Lancet Gastroenterol Hepatol; 2020 Dec; 5(12):1053-1062. PubMed ID: 33010814
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of irritable bowel syndrome-like symptoms using Rome IV criteria in patients with inactive inflammatory bowel disease and relation with quality of life.
Ozer M; Bengi G; Colak R; Cengiz O; Akpinar H
Medicine (Baltimore); 2020 May; 99(19):e20067. PubMed ID: 32384473
[TBL] [Abstract][Full Text] [Related]
18. Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices.
Langhorst J; Elsenbruch S; Koelzer J; Rueffer A; Michalsen A; Dobos GJ
Am J Gastroenterol; 2008 Jan; 103(1):162-9. PubMed ID: 17916108
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of functional dyspepsia-like symptoms in ulcerative colitis patients in clinical remission and overlap with irritable bowel syndrome-like symptoms.
Kotani S; Fukuba N; Kawashima K; Mishima Y; Sonoyama H; Okimoto E; Tada Y; Oka A; Tamagawa Y; Oshima N; Mishiro T; Tobita H; Shibagaki K; Moriyama I; Ishimura N; Kushiyama Y; Fujishiro H; Ishihara S
Scand J Gastroenterol; 2020 May; 55(5):560-564. PubMed ID: 32412797
[No Abstract] [Full Text] [Related]
20. Cognitive dysfunction in ulcerative colitis patients in remission and its comparison with patients with irritable bowel syndrome and healthy controls.
Sharma N; Dhiman S; Bodh V; Sharma D; Sharma R; Sharma S; Sharma B
Indian J Gastroenterol; 2021 Apr; 40(2):169-175. PubMed ID: 33417176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
